suPAR diagnostics
ViroGates develops and sells blood tests built around the suPAR biomarker. These tests help doctors and laboratories assess inflammation and disease severity and support clinical decisions in hospitals and other care set...
Decide at what price you'd be comfortable buying and we'll help you stay ready.
ViroGates A/S is a Danish medical diagnostics company that sells tests for measuring the suPAR biomarker in blood. Its main product family, suPARnostic, is used to help doctors assess a patient’s risk of serious illness and to support decisions about treatment and hospital care. The company does not make broad healthcare devices; it focuses on this one biomarker-based testing niche.
The company sells its tests to hospitals, laboratories, and other healthcare providers, often through distributors and partners in different markets. It makes money by selling test kits and related diagnostic products, and in some cases by licensing its technology or working with partners that integrate the test into their own systems. Its customers use the tests in settings such as emergency care, intensive care, and general patient assessment.
What makes ViroGates different is that it sits in the clinical diagnostics chain as a specialist rather than a large general lab company. It turns a single biological marker into a practical decision tool for doctors, which gives it a focused role in hospital diagnostics. That narrow focus can make the business easier to understand: it depends on how well its biomarker test becomes part of everyday medical workflows.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more